Researchers investigating the use of specific immunotherapy (SIT) to treat allergic diseases have conducted studies to confirm the long-term efficacy and tolerability of SIT and to identify the most effective route of SIT administration. The results of these studies were presented at the European Academy of Allergology and Clinical Immunology [Budapest, Hungary; June 1996].